These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29884719)

  • 1. Novel psychoactive substances: overdose of 3-fluorophenmetrazine (3-FPM) and etizolam in a 33-year-old man.
    Benesch MGK; Iqbal SJ
    BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29884719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple Drug-Toxicity Involving Novel Psychoactive Substances, 3-Fluorophenmetrazine and U-47700.
    Ellefsen KN; Taylor EA; Simmons P; Willoughby V; Hall BJ
    J Anal Toxicol; 2017 Nov; 41(9):765-770. PubMed ID: 28985320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse events related to the new psychoactive substance 3-fluorophenmetrazine - results from the Swedish STRIDA project.
    Bäckberg M; Westerbergh J; Beck O; Helander A
    Clin Toxicol (Phila); 2016 Nov; 54(9):819-825. PubMed ID: 27491700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Test purchase, synthesis and characterization of 3-fluorophenmetrazine (3-FPM) and differentiation from its ortho- and para-substituted isomers.
    McLaughlin G; Morris N; Kavanagh PV; Dowling G; Power JD; Twamley B; O'Brien J; Talbot B; Sitte HH; Brandt SD
    Drug Test Anal; 2017 Mar; 9(3):369-377. PubMed ID: 26810957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overdose of etizolam: the abuse and rise of a benzodiazepine analog.
    O'Connell CW; Sadler CA; Tolia VM; Ly BT; Saitman AM; Fitzgerald RL
    Ann Emerg Med; 2015 Apr; 65(4):465-6. PubMed ID: 25805032
    [No Abstract]   [Full Text] [Related]  

  • 6. Method validation and preliminary pharmacokinetic studies on the new designer stimulant 3-fluorophenmetrazine (3-FPM).
    Grumann C; Huppertz LM; Bisel P; Angerer V; Auwärter V
    Drug Test Anal; 2019 Jul; 11(7):1009-1017. PubMed ID: 30784204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity of designer benzodiazepines: A case of etizolam and cocaine intoxication.
    Drevin G; Briet M; Ferec S; Abbara C
    Forensic Sci Int; 2022 Jul; 336():111324. PubMed ID: 35525006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ distribution of diclazepam, pyrazolam and 3-fluorophenmetrazine.
    Lehmann S; Sczyslo A; Froch-Cortis J; Rothschild MA; Thevis M; Andresen-Streichert H; Mercer-Chalmers-Bender K
    Forensic Sci Int; 2019 Oct; 303():109959. PubMed ID: 31546164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of concurrent etizolam and tianeptine withdrawal following accidental overdose.
    Markovic M; Niwash D
    Ment Health Clin; 2022 Dec; 12(6):356-359. PubMed ID: 36644586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is etizolam a safe medication? Effects on psychomotor perfomance at therapeutic dosages of a newly abused psychoactive substance.
    Busardò FP; Di Trana A; Montanari E; Mauloni S; Tagliabracci A; Giorgetti R
    Forensic Sci Int; 2019 Aug; 301():137-141. PubMed ID: 31153990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etizolam: A rapid review on pharmacology, non-medical use and harms.
    Nielsen S; McAuley A
    Drug Alcohol Rev; 2020 May; 39(4):330-336. PubMed ID: 32243020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overdose from designer benzodiazepine Diclazepam.
    Runnstrom M; Kalra SS; Lascano J; Patel DC
    QJM; 2020 Feb; 113(2):122-124. PubMed ID: 31593281
    [No Abstract]   [Full Text] [Related]  

  • 13. The adulterated XANAX pill: a fatal intoxication with etizolam and caffeine.
    Kolbe V; Rentsch D; Boy D; Schmidt B; Kegler R; Büttner A
    Int J Legal Med; 2020 Sep; 134(5):1727-1731. PubMed ID: 32607751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of etizolam dependence.
    Gupta S; Garg B
    Indian J Pharmacol; 2014; 46(6):655-6. PubMed ID: 25538342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A patient with Parkinson's disease complicated by hypothyroidism who developed malignant syndrome after discontinuation of etizolam].
    Kawajiri M; Ohyagi Y; Furuya H; Araki T; Inoue N; Esaki S; Yamada T; Kira J
    Rinsho Shinkeigaku; 2002 Feb; 42(2):136-9. PubMed ID: 12424963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective observational study of emergency department presentations following novel psychoactive substance use.
    Henshall DE; Innes CW; Morrison SR; Wilson B; Brown RA; McAllister SM; Culshaw SL; Reda E
    Scott Med J; 2018 May; 63(2):39-44. PubMed ID: 29514583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing misuse of novel psychoactive substances.
    Solomon D; Grewal P; Taylor C; Solomon B
    Nurs Times; 2014 May 28-Jun 3; 110(22):12-5. PubMed ID: 24984370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of overlapping prescriptions of psychotropic drugs by community pharmacists.
    Shimane T; Matsumoto T; Wada K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2012 Oct; 47(5):202-10. PubMed ID: 23393998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic interactions between Japanese traditional Kampo medicine and modern medicine (IV). Effect of Kamisyoyosan and Tokisyakuyakusan on the pharmacokinetics of etizolam in rats.
    Makino T; Inagaki T; Komatsu K; Kano Y
    Biol Pharm Bull; 2005 Feb; 28(2):280-4. PubMed ID: 15684484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Can one talk of benzodiazepine "drunkenness"? About acute benzodiazepine intoxication, without suicidal or mortiferous tendencies].
    Menecier P; Texier MA; Las R; Ploton L
    Encephale; 2012 Feb; 38(1):25-30. PubMed ID: 22381720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.